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Abstract
The ocular surface is always attacked by oxidative stress, and cornea epithelial cells are supposed to have their own recovery
system against oxidative stress. Therefore we hypothesized that tears supply key molecules for preventing oxidative stress
in cornea. The potential target key molecule we focused is selenoprotein P (SeP). SeP is a carrier of selenium, which is an
essential trace element for many animals, for oxidative stress metabolism in the organism, and was extremely expressed in
lacrimal gland. An experiment was performed with SeP eye drops in a rat dry eye model, prepared by removing the lacrimal
glands. The anticipated improvement in corneal dry eye index and the suppression of oxidative stress markers were
observed in SeP eye drop group. Furthermore, the concentration of SeP was significantly higher in dry eye patients
compared with normal volunteers. Collectively, we concluded that tear SeP is a key molecule to protect the ocular surface
cells against environmental oxidative stress.
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Introduction
Ocular surface cells were most challenging cells for oxidative
stress, direct contact with the airflow, and light exposure including
ultraviolet irradiation. However eyes need to open and expose to
such environments for acquiring vision. To overcome such
environments, ocular surface cells (corneal and conjunctival
epithelial cells) are covered with tear film. If tear film lost their
balance of their components, tear film decrease their stability and
resulted in exposed directly in oxidative stress with dryness.
Although the severe case of dry eye syndrome was vision-
threatening diseases, and the number of patients is still increasing,
their molecular mechanism was poorly understood.
Tear film contains many kinds of working components [1]
which protect ocular surface cells against physical factors including
temperature [2], humidity [3], ultraviolet irradiation [4], and
airflow [5]. However no defined molecule was identified related to
the mechanism of dry eye syndrome. Among dry eye syndrome,
Sjogren’s syndrome is the well researched disease for dry eye, and
their ocular surface was dry due to decreased tear secretion from
the lacrimal glands. Therefore their dry eye results not only from
desiccation of the ocular surface, but also from the lack of tear
components essential for maintaining the ocular surface [6]–[7].
This could be partially explained by that autologous serum for the
treatment of severe dry eye resulted in dramatic improvement in
the ocular surface [8], but artificial tears could not. The
remarkable results using autologous serum led us to investigate
whether serum contains defined factors for the treatment of dry
eye.
Recently, dry eye was recognized as oxidative stress-induced
diseases. Selenium is an essential trace element for the human
body. Low selenium states have been associated with numerous
diseases, such as viral infection, reproductive dysfunction,
cardiovascular disease [9], and cancer [10]. SeP deficient mice
showed low level of selenium in brain, and short life span, rescued
by a high selenium diet. [11] For in vitro, selenium was necessary in
many types of cells, and promoted proliferation [12], which was
mainly supplied by fetal bovine serum (FBS) in culture medium.
Collectively, SeP, isolated through human serum fractionation,
was identified as key molecule for dry eye syndrome, and also
another candidate for treatment of dry eye.
Materials and Methods
Evaluation of oxidative stress in rat dry eye model
All animal experiments as follows were approved by the
Laboratory Animal Care and Use Committee of Keio University
School of Medicine. The dry eye rat model was prepared by
unilateral removal of the lacrimal gland [13]. Male 6-week-old
Sprague-Dawley rats (n=10 in each experiment) were purchased
from CLEA Japan, Inc. (Tokyo, Japan). The lacrimal gland was
surgically removed from the anesthetized rats. To estimate the
degree of dry eye, the ocular surfaces of rats were photographed
after being stained by fluorescein for scoring as follows. The
photographs of the corneas were divided into 9 areas. Each area
was scored from 0 to 3 points depending on degree of staining, and
the scores of all areas were totaled. This total was called the
‘fluorescein score’. Tear volume was measured with cotton thread
PLoS ONE | www.plosone.org 1 March 2010 | Volume 5 | Issue 3 | e9911as typical for clinical practice. The fluorescein score and tear
volume for each rat were measured before treatment and after 1,
2, 3, and 4 weeks of treatment. After 4 weeks of treatment, the
corneas were collected to measure 8-OHdG (8-hydroxy-29-
deoxyguanosine, a marker of oxidative DNA damage [14]) and
HEL (N
6-Hexanonyl lysine, an initial marker for oxidative damage
[15]). 8-OHdG and HEL were measured by High Sensitivity 8-
OHdG Check (Japan Institute for the Control of Aging, Fukuroi,
Shizuoka, Japan) and HEL ELISA Kit (Japan Institute for the
Control of Aging), respectively.
Effects of SeP eye drops treatment in rat dry eye model
The effect of SeP on treatment for dry eye was estimated by
applying SeP eye drops to the dry eye rat model. One eye in each
dry eye rat was treated with 5 or 50 mg/mL SeP or PBS, and the
other side was treated with PBS (n=10 in each group). Five mlo f
each eye drops was administrated 6 times per day for 3 weeks.
After all eye drop treatments, the corneal fluorescein scores were
estimated and the corneas were collected to measure the 8-OHdG
concentration. To avoid observer bias, the components of each eye
drops was kept blinded until after statistical analysis.
The measurement of oxidative stress in selenium-
deprived CEPI cells
To examine the influence of selenium deficiency on cellular
response against oxidative stress, we prepared selenium-deprived
cells using a selenium-deficient medium. Human corneal epithelial
cell line, CEPI-17-CL4 (CEPI) cells, was kindly provided by Dr.
Kuwahara (Alcon Laboratories, Fort Worth, TX). These immor-
talized cells were infected with a recombinant SV40-retrovirus
vector containing the Bg1I-HpaI fragment of SV40 T-antigen;
they express an extensive array of cytokines, growth factors, and
metabolic enzymes that resemble the original tissue [16]. CEPI
cells were cultured in serum-free medium (EpiLife supplemented
with HCGS; Cascade Biologics Inc., Portland, OR) with (Se+)o r
without selenium (Se2). Selenium deficiency was monitored every
week by measurement of glutathione peroxidase activity in the cell
lysate. GPx is a well-characterized selenoprotein, in which the
selenium atom is essential to catalyze the enzyme reaction. After
GPx activity diminished, 0, 0.5, 5, or 50 mg/mL SeP was added to
the medium and the cells were incubated 0, 1, 2, or 3 days to allow
uptake of SeP into the CEPI cells. To estimate the influence of SeP
uptake in CEPI cells during oxidative stress, GPx activity and the
8-OHdG and HEL content were measured. GPx activity was
measured using a GPx assay kit (Cayman Chemical Company,
Ann Arbor, MI, USA). The concentrations of 8-OHdG and HEL
in the cells were measured using a High Sensitivity 8-OHdG
Check and HEL ELISA Kit, respectively.
Effect of SeP against oxidative damage in
selenium-deprived CEPI cells
CEPI cells were grown under normal conditions to 80–90%
confluence in 96-well plates. To assay the production of
hydroperoxide in CEPI cells, 0.25 mM diphenyl-1-pyrenylpho-
sphine (DPPP) was added to the medium and the cells were
incubated for 24 hours. DPPP is a fluorescent reagent for
detection of hydroperoxide (Dojindo Laboratories, Mashikimachi,
Kumamoto, Japan). Cumene hydroperoxide (0.2 mM) was added
to the medium to cause oxidative damage to CEPI cells. SeP was
co-incubated with cumene hydroperoxide to protect against
production of hydroperoxide. Lipid peroxidation in the cells was
measured by Plate Reader (ARVO SX; PerkinElmer Japan Co.,
Ltd., Yokohama, Kanagawa, Japan).
SeP in human tears from dry eye patients
This study followed the guidelines of Institutional Review Board
and of the tenets of the Declaration of Helsinki. All study
participants signed informed consent documents prior to partic-
ipation. Two ml of human tears were obtained from healthy
volunteers (n=9) and dry eye patients (n=49) using capillary
collection. Tears were diluted approximately 240-fold by PBS with
0.05% Tween 20. The concentration of SeP was measured by
sandwich EIA. Dry eye was diagnosed according to published
criteria [17].
SeP expression in rat lacrimal gland
Corneas, hearts, kidneys, lacrimal glands, livers, muscles,
pancreases, and salivary glands were removed from rats (n=6).
Total RNA was extracted by GeneElute (Sigma-Aldrich Co.;
Chicago, IL, USA), and SeP expression was measured by real time
RT-PCR (ABI PRISM 7700 Sequence Detection Systems;
Applied Biosystems, Inc.; Foster City, CA, USA). All data were
analyzed with DDCt methods according to the manufacturer’s
protocol.
Results
Removal of lacrimal gland affected tear volume and
corneal damage, and increased oxidative stress
Unilateral removal of lacrimal glands led to decreased tear
secretion (Fig. 1a), and resulted in corneal erosion on the dry eye
side. Fluorescein scores for the dry eye corneas gradually
increased, while the cornea on the untreated side did not change
(Fig. 1b). Four weeks after removal of the lacrimal glands, the
fluorescein-stained areas on the dry eye side were larger than on
the normal side (Fig. 1c). The amount of 8-OHdG measured on
the dry eye side started to increase 3 weeks after removal of the
lacrimal gland (Fig. 1d). Four weeks after removal of the lacrimal
gland, the amounts of 8-OHdG (Fig. 1e) and HEL (Fig. 1f)
increased in the corneas of the dry eye side. Removal of the
lacrimal gland led to an increased fluorescein-stained area
accompanied by an increase in oxidative stress.
SeP partially recovered oxidative damage of cornea
Identification of SeP as candidate for the treatment of dry eye
was shown in Text S1 and Figure S1. SeP was identified from
fraction 32 fractionated by HiTrap Q HP column as most
effective component for treatment of dry eye. Figure 2 showed
the results after 3 weeks of SeP eye drops use. SeP eye drops
were clearly effective for suppression of corneal irritation
(Fig. 2a). The fluorescein score of corneas in normal rats (no
r e m o v a lo fl a c r i m a lg l a n d )r e m a i n e dl o w ,a n dP B St r e a t m e n t
did not suppress increased fluorescein scores in dry eye rat
(Fig. 2b). The fluorescein scores of corneas treated with SeP eye
drops were significantly lower than the scores following
treatment with PBS, and the effect was SeP dose dependent
(i.e., 50 mg/mL SeP eyedrops was more effective than 5 mg/mL)
(Fig. 2c). Furthermore, SeP eye drops suppressed production of
8-OHdG in corneas (Fig. 2d). We think that the decreased
fluorescein score seen with SeP eye drops was related to
suppression of oxidative stress.
Selenium deprivation in vitro induced oxidative stress
When CEPI cells were cultivated in selenium-deficient medium
for 2 weeks, GPx activity was diminished (Fig. 3). In inverse
proportion to GPx activity, the amount of HEL in CEPI cells
increased, as GPx catalyzed hydrogen peroxide and lipid
Selenoprotein P Protect Cornea
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uptake, recovered following the addition of SeP to the culture
medium. SeP was taken up by the CEPI cells; the selenium in SeP
was then used to synthesize GPx (Fig. 4a, b). The concentration of
SeP in Figure 4b was the same concentration as the eye drop
experiment. We expected that SeP was already sufficient in the
cells in 5 m/ml SeP stimulation. Both 8-OHdG (Fig. 4c) and HEL
(Fig. 4d) production were induced by selenium deprivation. The
elevation of both of these oxidative stress markers was reduced by
the addition of SeP. SeP uptake returned GPx activity to normal
levels, and consequently 8-OHdG and HEL production were
suppressed by GPx. Furthermore, SeP suppressed the lipid
peroxidation in CEPI cells induced by cumene hydroperoxide
(Fig. 5). Addition of 0.2 mM cumene hydroperoxide induced an
increase in lipid peroxide from 346826341 RFU (relative
fluorescent unit) (mean 6 S.D.) to 3702761171 RFU (mean 6
S.D.). Both 5 mM and 50 mM SeP concentrations significantly
suppressed production of lipid peroxide.
Figure 1. Preparation of dry eye rat model. a: Measurement of tear volume secreted from normal eye or lacrimal gland-removed eye of rats. The
vertical axis shows tear volume measured by cotton thread. Results are expressed as mean 6 S.D. Dunnett’s test was used to determine the
significance of differences. * and **indicates a significant difference from the result in normal side, P,0.05 and ,0.01, respectively. b: Corneal
fluorescein staining in normal rats and rats with dry eye. The vertical axis shows score of the fluorescein-stained area. Dunnett’s test was used to
determine the significance of differences. ** indicates a significant difference from the result at 0 week, P,0.01 (n=10). c: Photo of cornea stained by
fluorescein after 4 weeks treatment. d: Increase of marker during oxidative stress. Ratio of 8-OHdG content in the cornea between the dry eye and
normal eye. Results are expressed as mean 6 S.D. Dunnett’s test was used to determine the significance of differences. * and *** indicates a
significant difference from the result in 1-week removal, P,0.05 and ,0.005, respectively. e, f: Oxidative stress markers in cornea of normal rats and
rats with dry eye. Contents of 8-OHdG (e) and HEL (f) in a dry eye and normal corneas. t-test was used to determine the significance of differences.
* indicates a significant difference from the result in normal side, P,0.05. Results are expressed as the mean 6 S.D. (n=10).
doi:10.1371/journal.pone.0009911.g001
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drop administration. b: Fluorescein score of cornea in normal rats (Normal), in dry eye rats treated with PBS (PBS, closed bar). Results are expressed as
mean 6 S.D. Dunnett’s test was used to determine the significance of differences. * and *** indicates a significant difference from the result in PBS
treatment, P,0.05 and ,0.005, respectively. c: Fluorescein score of cornea in dry eye rat treated with PBS or SeP. d: Ratio of 8-OHdG content in
cornea of dry eye between SeP and PBS treatment. Results are expressed as mean 6 S.D. T-test was used to determine the significance of differences.
*, **, and *** indicates a significant difference from the result in PBS treatment, P,0.05, ,0.01, and ,0.005, respectively (n=10).
doi:10.1371/journal.pone.0009911.g002
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Although SeP had been found in plasma, it was not known
that SeP was present in human tears. We measured the
concentration of SeP in human tears, finding SeP in tears of
healthy volunteers at a concentration of 93.1657.1 ng/mL
(mean 6 S.D.). We also measured the concentration of SeP in
tears of dry eye patients, finding a mean concentration of
56.1630.0 ng/mL (mean 6 S.D.) (Fig. 6a). The concentration
of SeP in non-dry eye patients was significantly higher than that
in dry eye patients (p=0.01), as evaluated by fluorescein score
(Fig. 6a), and a similar result was obtained with Rose Bengal
scoring (Fig. 6b).
SeP expression in the rat lacrimal gland
To examine whether SeP was synthesized in the lacrimal gland
or not, SeP mRNA expression was measured in lacrimal glands.
RNA was extracted from rat lacrimal glands, liver, and other
tissues because of the comparison of SeP expression levels in
lacrimal gland and other tissues with that in liver, in which SeP in
plasma is primarily produced. SeP expression in rat lacrimal
glands was approximately 50% of in rat liver, and that in other
tissues were below 15% (Fig. 6c). This result suggested SeP was
extremely expressed in the lacrimal glands compared with in the
other tissues.
Discussion
One of the serum-derived candidates for the treatment of dry
eye is serum albumin [18]. The concentration of albumin in serum
is approximately 50 mg/mL and which was about 50% of the
serum protein [1]. Serum albumin is a remarkably stable, and
distributed widely in body fluids including tears [19]. The
Figure 3. Effect of selenium deficiency on CEPI cells. Selenium
deficiency-induced GPx activity and HEL production in CEPI cells. Open
triangle shows the ratio of GPx activity and closed cycle shows ratio of
HEL content. Data are mean 6 S.D. (n=6).
doi:10.1371/journal.pone.0009911.g003
Figure 4. SeP addition suppresses oxidative stress in selenium-deficient CEPI cells. a: Recovery of GPx activity by addition of SeP. Fifty mg/
mL SeP was added to culture medium and incubated for 0, 1, 2, or 3 days. ** indicates a significant difference from the result in Se-, P,0.01 (n=8). b:
Recovery of GPx activity by addition of SeP (5 or 50 mg /mL) and incubated for 3 days. **P,0.01 and ***P,0.005, respectively (n=6). c, d: Suppression
of production of 8-OHdG. (c, n=8) and HEL (d, n=5) in CEPI cells. SeP (0.5, 5 or 50 mg /mL) was added to medium and cells were incubated for 3 days.
*P,0.05. All results are expressed as mean 6 S.D. Dunnett’s test was used to determine the significance of differences. Se+: GPx activity of CEPI cells
cultivated in normal medium. Se-: GPx activity of CEPI cells cultivated in selenium-depleted medium.
doi:10.1371/journal.pone.0009911.g004
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approximately 1% of the protein in tears [1]. In our previous
study, 50 mg/mL albumin was applied as eyedrops for patients
with severe dry eye caused by Sjogren’s syndrome [20]. The
patients showed significant improvement in both their fluorescein
and Rose Bengal scores, but the differences were not noted in tear
break-up time or subjective symptoms.
Other possible candidates are tear components such as
epidermal growth factor and retinoic acid in serum [1] as
previously reported [21], which played an important role in the
maintenance of the ocular surface. However these components
may be useful for the treatment of dry eye, but they are not
sufficiently efficacious; for this reason, we wanted to identify other
serum-derived candidates.
The physiological role of selenium is probably its incorporation
into selenocysteine (Sec), cysteine analogue with a sulfur atom
replacing a selenium atom. The protein containing of Sec is called
selenoprotein. Twenty-five selenoprotein genes are present in the
human genome, but little beyond genomic data is known about many
of them [22]. GPx was the first selenoprotein identified in mammals
[23]. GPx consists of several isozymes and acts to protect cells from
oxidative damage by catalyzing the reduction of H2O2,l i p i d
hydroperoxides, and other organic peroxides. Since Sec residue is
contained in the active site of GPx, Sec is thought to be essential for
activity [24]. GPx is widely distributed in tissues of the body including
the ocular surface [16], [25]. Figure 3 shows the reduction of GPx
activity in CEPI cells cultivated in selenium-deficient medium. This
reduction was caused by cellular Se exhaustion, because Sec residue is
essential for GPx activity. Reduction of GPx activity reduce the
capacity to prevent anti-oxidative damage and induced 8-OHdG and
HEL accumulation in the cells.
SeP is selenium-transfer plasma glycoprotein [26] and is present in
extracellular fluids such as plasma [27] and milk [28]. The principal
source of SeP is thought to be the liver [29]. In this paper, we report
that SeP found in tears (Fig. 6) and was synthesized in the lacrimal
gland. SeP contains ten Sec residues; one Sec is located at the 40th
residue in the N-terminal, and other residues are localized in the C-
Figure 6. SeP in tears. a, b: Concentration of SeP in human tears. Fluorescein (a) and Rose Bengal (b) Scores are indices of dry eye diagnosis. Dry
eye is indicated with fluorescein scores of $1, or when the Rose Bengal Score is $3. c: SeP expression in rat lacrimal glands. The vertical axis shows
expression level of SeP in each tissue compared with liver. The expression level in the liver defined 1. All results are expressed as mean 6 S.D.
doi:10.1371/journal.pone.0009911.g006
Figure 5. SeP suppresses lipid peroxidation in CEPI cells. The
vertical axis shows peroxidation rate calculated from fluorescence
intensity. Results are expressed as the mean 6 S.D. (n=4). Dunnett’s
test was used to determine the significance of differences. ** and ***
indicate a significant difference from the result of 0 mg/mL SeP addition,
P,0.01 and ,0.005, respectively.
doi:10.1371/journal.pone.0009911.g005
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N-terminal shows GPx activity [31] and Sec residues in C-terminal
are functioned as cellular selenium suppliers [32]. Although SeP did
not reduce H2O2, it could reduce phospholipids hydroperoxide [33].
SeP blocked ultraviolet-induced cell death [33] (which is related to
production of active oxygen) and fatty acid hydroperoxide-induced
cell death [34].
Figure 2 shows improvement of dry eye by treatment with
50 mg/mL SeP. This effect is thought to be due to two functions of
SeP, i.e. GPx activity and Sec supply activity. The function of SeP
as selenium supplier may be more important than the function to
reduce the effect of anti-oxidative stress on corneas. Attempts to
measure the content of selenium in corneas of normal rats using
X-ray absorption fine structure methods were unsuccessful
because of the low content of selenium (data not shown). We
hypothesized that reduction of tear volume secreted from the
lacrimal gland reduced the selenium supply to the cornea from
tears, and easily induced a shortage of selenium in the cornea. A
shortage of selenium led to an increase in oxidative stress in
corneal cells accompanied by diminished GPx activity (Fig. 3). It
was shown in this (Fig. 1) and a previous paper [5] that oxidative
stress increased in corneas of the dry eye rat model. SeP supply is
thought to increase selenium content and, as a result, revive GPx
activity in the cornea.
Selenium source of supply to cornea epithelium is probably SeP
in the tears. Because SeP is expressed in the rat lacrimal gland
(Fig. 6c), SeP in the tears is thought to synthesize and secreted
from the lacrimal gland. It is supposed that highly expression level
of SeP in the lacrimal gland is necessary for sufficient supply of
selenium to the cornea. High concentrations of lipid peroxide were
detected in dry eye patients compared with tears from normal
controls [35]. Our results suggest that oxidative stress increases in
the ocular surface of dry eye. In the tears from patients who have
corneal damage, the SeP concentration was lower than control
(p=0.001, Fig. 6a). The content of selenium in the corneas may be
reduced by the low level of SeP in the tears of those patients.
Ocular surface cells are damaged by physical and chemical
factors which induce oxidative stress. SeP in tears physiologically




Found at: doi:10.1371/journal.pone.0009911.s001 (0.03 MB
DOC)
Figure S1 Identification of candidate for dry eye treatment from
human plasma. a: Treatment effect of fraction 41-h on corneal
epithelial erosion induced by ocular surface desiccation. Results
are expressed as mean 6 S.D (n=6). Paired Student’s t-test was
used to determine the significance of differences. * indicates a
significant difference from the result of PBS treatment, P,0.05. b:
Fractionation of Fraction 41-h using HiTrap Q HP chromatog-
raphy. The vertical axis shows ratio of DNA fragmentation of each
fraction compared with HiTrap Q HP-applied solution (Fraction
41-h). c: SDS-PAGE pattern of Fraction 31. Marker: molecular
weight marker; Fr32: Fraction 32.
Found at: doi:10.1371/journal.pone.0009911.s002 (1.71 MB TIF)
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